CAS 701213-36-7
:BMS-626529
Description:
BMS-626529 is a chemical compound that belongs to the class of small molecules and is primarily recognized for its role as an antiviral agent. It has been investigated for its potential efficacy against certain viral infections, particularly those caused by the hepatitis C virus (HCV). The compound functions as a non-nucleoside polymerase inhibitor, which means it interferes with the viral replication process by targeting the polymerase enzyme essential for viral RNA synthesis. BMS-626529 exhibits a favorable pharmacokinetic profile, which includes good oral bioavailability and a manageable half-life, making it a candidate for therapeutic use. Its chemical structure features specific functional groups that contribute to its biological activity and selectivity. As with many investigational drugs, ongoing research is essential to fully understand its safety, efficacy, and potential side effects in clinical settings. Overall, BMS-626529 represents a significant advancement in the search for effective antiviral therapies.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Temsavir
CAS:<p>Temsavir (BMS626529) is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells.</p>Formula:C24H23N7O4Purity:99.14%Color and Shape:SolidMolecular weight:473.48Temsavir
CAS:Controlled Product<p>Applications Temsavir is a Fostemsavir (CAS# 864953-29-7) intermediate and an antiviral agent. It is an HIV-1 attachment inhibitor.<br>References Landry, I., et al.: Antimicrob. Agents Chemother., 60, 2782-2789 (2016);<br></p>Formula:C24H23N7O4Color and Shape:BeigeMolecular weight:473.4839Temsavir
CAS:<p>Temsavir is a cyclic peptide that is chemically similar to the HIV-1 gp120 protein. It binds to the gp120 receptor on the outside of the virus and inhibits viral life, inhibiting viral replication and infectivity. Temsavir has been shown to be an inhibitor of HIV-1 in vivo human pharmacokinetics. The oral prodrug temsavir has been shown to be effective for the treatment of infectious diseases caused by HIV-1, such as hepatitis C virus (HCV) co-infection. Temsavir can also be used for hepatic impairment, which may not respond well to other drugs because they are primarily metabolized in the liver.</p>Formula:C24H23N7O4Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:473.48 g/mol
